CAS No. 86327-76-6

Guanosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-(tetrahydro-2-furanyl)-

Identification

Catalog number	1175944
Chemical name	Guanosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-(tetrahydro-2-furanyl)-
CAS RN	86327-76-6
Molecular formula	C39H43N5O9

Structure

Classification

Send Inquiry Safety information

About Guanosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-(tetrahydro-2-furanyl)-

Guanosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-(tetrahydro-2-furanyl)- is a chemical compound registered under CAS number 86327-76-6, with the molecular formula C39H43N5O9 and a molecular weight of about 725.8 g/mol. CMSTrade supplies Guanosine,5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-(2-methyl-1-oxopropyl)-2'-O-(tetrahydro-2-furanyl)- for laboratory research and bulk production; product code 1175944. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 86327-76-6
Molecular Formula: C39H43N5O9
Molecular Weight: 725.8 g/mol

Related Keywords

furanyl

guanosine

oxopropyl

phenylmethyl

methoxyphenyl

Furan

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-(2-methyl-1-pyrrolidinyl)-5-nitrobenzoyl]-

Urea, N-(3-chloro-4-cyanophenyl)-N'-(3-methylphenyl)-

Piperazine, 1-(5-cyano-2-pyridinyl)-4-[2-(4-morpholinyl)-5-nitrobenzoyl]-

2-Butenedioic acid, 2-methyl-3-(phenylmethyl)-, sodium salt (1:2), (2Z)-

Piperazine,1-[4-chloro-3-(trifluoromethyl)phenyl]-4-[2-(4-morpholinyl)-5-nitrobenzoyl]-

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-(methylpropylamino)-5-nitrobenzoyl]-

847968-72-3

Benzeneacetic acid, a-[1-[4-(methylsulfonyl)phenyl]ethylidene]-, methylester, (E)-

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-N,3,6,6-tetramethyl-N-(4-nitrophenyl)-, monohydrochloride

Imidazo[2,1-b]thiazole, 3-(3,4-dimethylphenyl)-5,6-dihydro-,monohydrobromide

Imidazo[2,1-b]thiazole, 5,6-dihydro-3-(4-methoxyphenyl)-

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-3-methyl-N-(1-methylethyl)-N-[3-(trifluoromethyl)phenyl]-

5-(3,5-dimethylbenzyl)-6-ethyl-3-(2-hydroxyethoxy)-2,3-dihydro-7H-[1,3]thiazolo[3,2-a]pyrimidin-7-one

199852-24-9

2-methyl-2-(4-nitrophenyl)oxirane

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-N-(2-methoxyphenyl)-3,6-dimethyl-

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-3,5,6-trimethyl-N-[[3-(trifluoromethyl)phenyl]methyl]-

4-chloro-6-methoxy-7-(2-(pyrrolidin-1-yl)ethoxy)quinazoline

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[5-nitro-2-(2-propenylamino)benzoyl]-

2-Butenoicacid, 4-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-, methyl ester, (2E)-

194093-31-7

Imidazo[2,1-b][1,3]thiazepin-3(2H)-one,5,6,7,8-tetrahydro-2-[[2-(trifluoromethyl)phenyl]methylene]-, (2Z)-

2-Butanone, 3-methyl-4-[[tris(1-methylethyl)silyl]oxy]-, (3S)-

Lithium, m-1,2-ethanediyldi-

Hexadecanamide, 16-mercapto-N-[2-[4-(phosphonooxy)phenyl]ethyl]-

Hexadecanoic acid, 2-chloropropyl ester

Lithium, compd. with silver (4:4)

873334-94-2

Hexadecanoic acid, 2-(4-methylphenoxy)-, ethyl ester

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-N,3-dimethyl-N-(2-phenylethyl)-

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[2-(methylamino)-5-nitrobenzoyl]-

Imidazo[2,1-b][1,3]thiazepin-3(2H)-one,2-[[4-(benzoyloxy)phenyl]methylene]-5,6,7,8-tetrahydro-, (2Z)-

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[5-nitro-2-(1-pyrrolidinyl)benzoyl]-

Piperazine,1-(4-acetyl-2-fluorophenyl)-4-[5-nitro-2-[(tetrahydro-2H-pyran-4-yl)amino]benzoyl]-

847968-67-6

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-3-methyl-N-[[3-(trifluoromethyl)phenyl]methyl]-

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-N-(3-iodophenyl)-3,6-dimethyl-

Thiourea,N-ethyl-N'-[3-[2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl]phenyl]-,dihydrochloride

Hexadecanoic acid, 2-(3-hydroxyphenyl)ethyl ester

Imidazo[2,1-b]thiazole-2-carboxamide,5,6-dihydro-N,3,6,6-tetramethyl-N-[[3-(trifluoromethyl)phenyl]methyl]-

5-bromo-3-methyl-2-(methylthio)-6-(pyridin-4-yl)pyrimidin-4(3H)-one